Resources
Covid-19 Resources

Covid-19 Resources

In December 2019, a new strain of human coronavirus was detected – initially called 2019-nCoV – in few patients with viral pneumonia in Wuhan, China. The EAACI community is united in disseminating new research and knowledge on the COVID-19 pandemic. Find some of the most useful related content here to better serve you and your patients. More resources on COVID-19 will be added as they are released by our community of experts.

All Covid-19 Resources

Filter

What are you looking for?

Category
- adolescent
- aerobiology and pollution
- allergen immunotherapy (AIT)
- AllergoOncology
- allergy asthma and a sport
- allergy diagnosis
- allied health and primary care
- anaphylaxis
- angioedema
- artificial intelligence (AI)
- asthma
- basic immunology
- biologicals
- comparative veterinary allergology
- consensus document
- COVID-19
- dermatology
- drug allergy
- EAACI position paper
- EAACI Task Force report
- ENT
- environmental allergy and climate change
- eosinophilic esophagitis (EoE)
- epidemiology
- epithelial cell biology
- exposome
- food allergy
- food allergy and anaphylaxis
- genomics and proteomics
- hypersensitivity
- immune deficiencies and autoimmunity
- immunomodulation and nutrition
- infections
- insect venom hypersensitivities
- mastocytosis and mast cells
- microbiome
- nasal polyposis
- occupational allergy
- ocular allergy
- OMIC technologies in allergy research
- One Health
- pediatrics
- prevention
- systems medicine
- T2 diseases
- transitional
Year
- 2013
- 2014
- 2015
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
Keywords
- nasal polyps…)
- sinusitis
- vaccines and mechanisms
- “omics” and systems biology
- “omics” and systems biology
- (reverse) zoonosis
- AAMP
- Abbott Laboratories
- Abdominal pain
- ABPA
- ACE2
- Acoustic rhinometry
- Adherence
- Adjuvant
- Adjuvants
- adolescent
- Adolescents
- adolesent and young adult (AYA)
- Adrenaline
- Adrenaline auto-injector
- adult
- adults
- adverse drug reaction
- advocacy
- aerd
- aerobiology
- aerosolization
- AGREE II
- Aimmune Therapeutics
- Air pollutant
- Air pollution
- Airborne enzyme
- airways
- AIT
- Algorithm
- ALK
- allegen immunotherapy (AIT)
- allergen
- allergen exposure challenge
- allergen exposure chamber
- allergen immunotherapy
- allergen immunotherapy (AIT)
- Allergen labelling
- Allergen sequence database
- allergen symphony
- Allergen-free foods
- Allergens and epitopes
- allergens and epitopes
- allergic asthma
- allergic bronchopulmonary aspergillosis
- allergic conjunctivitis
- Allergic conjunctivitis (AC)
- Allergic contact dermatitis
- allergic disease
- allergic diseases
- allergic rhinitis
- Allergic rhinitis (AR)
- allergicdiseases
- allergicrhinitis
- allergies to cats
- allergoid-mannan conjugates
- AllergoOncology WG
- Allergopharma
- allergy
- allergy diagnosis
- Allergy diagnosis
- allergy epidemiology
- allergy hypersensititvy
- allergy immunotherapy
- allergy management
- Allergy risk
- allergy test
- allergy therapeutics
- allergy treament
- allergy treatment
- Allergy treatment
- allergy/hypersensitivity
- alpha-gal allergy
- ALR
- Alternaria
- altitude
- Anaphylaxis
- Angioedema
- angiotensin-convertingenzyme2
- angiotensin-convertingenzymeII
- Animal models
- Anosmi
- anti-epileptic drugs
- antibiotics
- Antibodies
- antibody
- antibody-dependentenhancement
- antibodydynamics
- antigen presenting cells
- Antolimab
- Api m 10
- APOE
- ARPC1B
- Artificial intelligence
- Asthma
- asthma care
- asthma control
- asthma exacerbations
- asthma inflammatory
- asthma management
- asthma risk
- Asthma treatment
- Asthma treatment
- asthmatic patients
- Astrazeneca
- asymptomatic
- atopic dermatitis
- Atopic dermatitis
- Atopic dermatitis (AD)
- Atopic deseases
- Atopic eczema
- Atopic eosinophilic asthma
- atopy
- Autoallergen
- Autoimmunity
- Autoinflammation
- Avapritinib
- Azelastine fluticasone
- B cells
- B regulatory cells
- bacterial lysate
- bacterial lysates
- bacterial mucosal immunotherapy
- bacterial products
- Barrier
- Basic and Clinical Immunology Section
- Basic immunology
- basic mechanisms
- Basic mechanisms
- Basophil
- Basophil activation test
- basophil activation test (BAT)
- Bathing
- Bcells
- Beijing
- Benralizumab
- berotralstat
- Bet v 1
- beta-lactam
- beta-lactoglobulin
- Big data
- bigdata
- BioCryst
- Bioinformatics
- Biological detergents
- biologicals
- Biologics
- biomarker
- Biomarkers
- biosafety
- Biotin
- Birch
- Birch pollen
- blood
- blood eosinophil
- BluePrint Medicines
- BNT162b2
- Bovine milk
- Breast milk
- Breastfeeding
- Breg cells
- bronchial allergen challenge
- bronchial asthma
- bronchial thermoplasty
- bronchiectasis
- Bronchiolitis
- Bronchoconstriction
- BTK
- c-kit
- C1 inhibitor
- C1-INH
- cabbage
- cancer
- cannabis allergy
- case study
- cats
- causality
- Cellular test
- challenge tests
- Challenge tests
- chemotherapy
- Childhood allergies
- childhood asthma
- childhoodvaccination
- children
- china
- chlorhexidine
- chlorination by-products
- Chronic respiratory
- Chronic rhinosinusitis
- Chronic rhinosinusitis with nasal polyposis (CRSwNP)
- chronic rhinosinusitis with nasal polyps (CRSwNP)
- chronic spontaneous urticaria
- Chronic spontaneous urticaria (CSU)
- chronic urticaria
- chronicrhinosinusitis
- chronicrhinosinusitiswithnasalpolyps
- chronicurticaria
- chronis rhinosinusitis
- classification
- climate
- climate change
- Clinical aspects
- clinical cases
- clinical endotypes
- Clinical immunology
- Clinical immunology Food allergy
- Clinical practice
- clinical tolerance
- clinical trials
- clinicalimmunology
- Cluster analysis
- CMA
- Collegen-binding receptor
- common cold
- companion animals and pets
- Company Sponsored Symposia
- complex world of allergy
- compliance
- component resolved diagnosis
- Component resolved diagnosis (CRD)
- component-resolved diagnosis (CRD)
- Conjunctiva
- conjunctivitis
- Consensus
- consensus document
- contact allergen
- contact dermatitis
- Contact urticaria
- containment
- contraindications
- coronavirus
- coronavirusdisease2019
- Cost-effectiveness
- cough
- COVID
- COVID-19
- COVID-19 lockdown
- COVID-19 pandemic
- COVID-19 vaccine
- COVID-19 vaccines
- COVID-19[SupplementaryConcept]
- COVID-19diagnostictesting[SupplementaryConcept]
- COVID-19vaccines
- COVID‐19
- COVID19
- Cow's milk
- Cow's milk allergy
- CRISPR
- criticalillness
- Cross-reactivity
- CRSwNP
- CSL Behring
- Cutaneous manifestation
- cyclosporine
- cytokine
- DAMP
- danger signals
- Danger signs
- Danone/Nutricia
- dbv technologies
- dbv712
- Deep learning
- delabelling
- DELPHI
- Dendritic cells
- dermatologic diseases
- Dermatology
- desensitization
- dexamethasone
- DGAKI
- diagnosis
- diet
- dietary management
- Differential diagnosis
- digital anamorphosis
- disease (CRD)
- disease burden
- disease control
- disease model
- disease transmission
- disinfection by-products
- disruptive IgE antibody
- DNase
- Drug allergy
- drug allergy
- Drug desensitisation
- Drug hypersensitivity
- drug provocation test
- drug provocation test (dpt)
- Drug provocation tests
- dupilumab
- Dysbiosis
- E-cigarette
- eaaci hybrid congress 2021
- eaaci hybrid congress 2022
- eaaci2021
- early diet
- ECDA
- ecosystem
- eczema
- Education
- EETosis
- efficacy
- Egg allergy
- EGR-1
- eHealth
- Eldery
- Elimination diet
- Emollient
- Endotype
- Endotypes
- ENT
- ENT (rhinitis
- environment
- Environment and hygiene hypothesis
- Environment and Immunology StandUp Talks
- Environmental exposure chamber (EEC)
- environmentalhealth
- Enzyme-LinkedImmunosorbentAssay[Mesh]
- eosinophil
- eosinophilic diseases
- eosinophilic fasciitis
- Eosinophilic granulomatosis with polyangiitis (EGPA)
- Eosinophils
- Epicutaneous
- Epicutaneous immunotherapy
- Epidemiology
- epigenetic
- Epithelial barrier
- Epithelial barrier hypothesis
- epithelialcell
- Epithelium
- Epitome
- Epitope specific IgA
- Esophagitis
- EU
- European parliament
- evidence-based
- exacerbations
- exercise
- Exercise induced anaphylaxis (EIAn)
- Exercise induced asthma
- exposome
- faam-eurobat digital 2020
- Faes Farma
- fermentedvegetable
- fiber
- Flow cytometric
- Flow cytometry
- flow-diagram
- flowcytometry
- food additives
- food allergy
- Food allergy
- Food aversion
- food labelling
- Food processing
- food protein induced enterocolitis syndrome (FPIES)
- Food-dependent exercise-induced anaphilaxis (FDEIAn)
- Food-induced anaphylaxis (FIA)
- Fungi
- fungus
- Gene expression
- Genetics
- Genome-wide association study (GWAS)
- Global air quality
- global atlas
- glycans
- GRADE
- Grant application
- GSK
- guidelines
- gut microbiome
- Gut microbiota
- HAE
- HAL Allergy
- healthier environment
- Helicobacter pylori
- Helminth infection
- hereditary angioedema
- Hereditary angioedema (HAE)
- Histamine
- Histamine intolerance
- hives
- HMO
- Hologenome
- House dust mite
- House dust mite (HDM)
- house dust mites
- Human bronchial smooth muscle cells (BMSC)
- hygiene
- Hypereosinophilic syndrome (HES)
- hyperinflammation
- hypersensitivity
- hypersensitivity reactions
- ICD-11
- IgE
- IL-37b
- imaging
- Immune amnesia
- Immune deficiencies
- Immune health
- immune phenotype
- immune response
- immune system
- Immune tolerance
- immunecomplex
- immuneresponse
- Immunization
- immunodeficiencies
- immunoglobulinM
- immunoglobulins
- Immunologic tests
- Immunologic tests
- immunology
- Immunomodulators
- immunotherapy
- Immunotherapy and tolerance induction
- Immunotherapy clinical
- Immunotherapy vaccines and mechanisms
- Immunotherapy vaccines and mechanisms
- implementationscience
- In vitro assays
- Inborn errors of immunity (IEI)
- Infections
- inferiorturbinate
- Inflammasome
- Inflammation
- Inflammatory bowel disease (IBD)
- inflammatoryendotype
- innate immune training
- Innate immunity
- innate immunity
- Innate lymphoid cells and NK cells
- innateimmunity
- Innovation
- Insect Venom Allergy
- insects
- integrated care
- Integrines
- interferon
- Interferons
- Interleukins
- international classification of diseases (ICD)
- international consensus
- intradermal test
- Iodinated contrast media
- italy
- itch
- Kawasakisyndrome
- kimchi
- Lactobacillus
- lanadelumab
- learning methods
- LETI Pharma
- ligelizumab
- Lipid transfer protein (LTP)
- Local allergic rhinitis
- Lolium Perenne
- long-term immunity
- Long-term prophylaxis
- LTRA
- Lung diseases other than asthma and COPD
- lung function
- lung function test
- Lung function tests
- lymphocyte transformation test (LTT)
- Lymphocytes
- Machine learning
- Macrophages
- Malignant
- management
- marketing authorization
- Masitinib
- mast cell
- Mast cells
- Mast cells
- Mast cells Dermatology
- mastocytosis
- Mastocytosis scale (QLMS)
- mechanisms
- Medthority CME supported by Novartis
- memory B cells
- Menarini Group
- mental health
- Mepolizumab
- Metabolite
- metabolites
- Metabolomics
- Metalloproteinase 9
- methods
- mHealth
- Microbial Disease
- microbial products
- Microbiome
- microbiota
- MicroCrystalline
- micronutrient
- MicroRNA (miRNA)
- Mobile health (mHealth)
- Moisturisers
- Molecular phenotypes
- molecularinteractionassay
- Molecules
- monoclonal Abs
- monocytes
- MOOC
- MRGPRX2
- mRNA
- mRNA vaccines
- Multiple myeloma
- multisystem allergy
- multisysteminflammatorysyndrome
- mumps‐measles‐rubella
- myeloperoxidase
- nasal allergen challenge
- nasal endoscopy
- nasal polyposis
- nasal polyps…)
- neonates
- Nestlé Health Science
- Nestlé Nutrition Institute
- Neuroimmunology
- Neuronal control
- Neutralizing[Mesh]
- neutralizingantibody
- neutrophil extracellular traps (NETs)
- neutrophilextra-cellulartraps(NETs)
- neutrophils
- New challenges
- newborns
- Next generation
- NLR
- non-specialist care
- non-steroidal anti-inflammatory drugs (NSAID)
- non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
- noninvasive diagnosis
- Noucor
- Novartis
- Novel mechanisms
- NSAID
- nsaid-exacerbated respiratoy disease (NERD)
- Nutrition
- Obesity
- Occupational asthma
- occupational exposure
- Ocular allergy
- older (adults/people)
- older adults
- Olfactory disturbance
- Olink
- OM Pharma
- omalizumab
- omic
- One Health
- OneHealth
- Oral allergy syndrome (OAS)
- oral challenge
- oral food challenge
- Oral immunotherapy
- outbreak
- Outcome measures
- PAAAM 2021
- PAAM 2021
- PAAM Digital 2021
- paediatric awareness
- Paediatrics
- PAF
- PAMP
- Panallergen
- pandemic
- Particular matter (PM)
- Patch test
- Patch tests
- patient care
- patient reported outcome
- peak expiratory flow
- peak expiratory flow (PEF)
- Peanut
- Peanut allergy
- pediatric
- pediatric aspects
- pediatric asthma
- pediatric atopic dermatitis
- pediatrics
- Peptide immunotherapy
- perioperative allergy
- personalized medicine
- Personalized medicine
- pharmacoeconomics
- Pharmacology and pharmacogenomics
- Pharming
- Phase-3 study
- Phenotype
- phenotypes
- physiology
- Pine nut allergy
- PIPEline
- Placebo effect
- placebo effects
- Plane tree
- Platanus hybrida
- Pneumology
- pneumonia
- Polish Allergology Society
- Pollen
- Pollen food syndrome
- Pollen forecast
- Pollen monitoring
- pollutants
- pollution
- polyethilen glycol
- polyethylene glycol
- PRACTALL
- prebiotics
- Precision medicine
- precision medicine
- prediction
- Prediction model
- Pregnancy
- Prematurity
- Prevention
- primary care
- primary immunodeficiency
- Probiotic
- probiotics
- proctocolitis
- Prophylactic Treatment
- proresolvinglipids
- protection
- protectiveantibodies
- protein contact dermatitis
- proteomics
- Proteotomics
- Proton pump inhibitor
- pruritus
- Psoriasis
- psychological effects
- psychology
- pulmonary rehabilitation
- Purina Institute
- Quality-of-life
- qualitycriteria
- Questionnaire
- race
- Ragweed
- randomized controlled trial
- Rapid drug desensitization
- Real life
- real-life
- real-world evidence
- Recipe
- recreational exposure
- RED-ZONE
- Regulatory aspects
- regulatory authorities
- Relegating OCS to last resort: Creating a paradigm shift in asthma management
- Remodelling
- reslizumab
- respiratory allergies
- respiratory allergy
- Respiratory infections
- Revenio
- Rhinitis
- Rhinitis Monitoring
- Rhinoconjunctivitis
- Rhinosinusitis (RS)
- Rhinovirus
- risk assessment
- risk factors
- riskfactors
- RLR
- rupatadine
- safety
- SAM 2021
- SAM2021
- SANI
- Sanofi Regeneron
- SARC-CoV-2
- SARS-CoV
- SARS-CoV-2
- SARS-CoV-2 vaccine
- SARS‐CoV‐2
- Satellite Symposia
- SCARs (severe cutaneous adverse drug reactions)
- scientific career
- scoring system
- self‐management
- sensitization
- sensitization profile
- Sepsis
- sequencing (NGS)
- severe allergic reactions
- severe asthma
- Severe cutaneous adverse drug reactions (SCARs)
- severe cutaneous adverse drug reactons
- severe eisinophilic asthma
- severe type 2 asthma
- SevereAcuteRespiratorySyndromeCoronavirus2[SupplementaryConcept]
- severeallergicreactions
- severity
- sIgG
- Single nucleotide polymorphisms (SNPs)
- sinus
- sinusitis
- Skin
- skin allergy
- Skin barrier
- skin diseases
- skin test
- Skincare
- sleep pattern
- smell
- SoMe
- Spirometry
- sport
- Sports
- sputuminduction
- Stallergenes Greer
- standardization
- StandUp Talks
- Stevens-Johnson syndrome (SJS)
- Stratification
- subcutaneous immunotherapy
- Sublingual
- sublingual immunotherapy
- sulforaphane
- Sulfur mustard Stem cells
- survey
- Symptom scale
- Symptom score
- synbiotics
- system biology
- systematic mastocytosis
- Systemic mastocytosis (SM)
- T cells
- T cells
- t2 diseases
- Takeda
- TAKHZYRO
- Tcells
- technical standards
- teenager
- tele-health
- teleHealth
- telemedicine
- Terriers
- Tezepelumab
- Th2 cell
- Th2 sensitization
- therapies
- Thermo Fisher Scientific
- threshold dose
- Thunderstorm asthma
- TLR
- TMPRSS2
- tolerance
- Trained immunity
- trainedimmunity
- Transcriptome
- Transcriptomics
- transition
- Transition process
- translationalresearch
- transmissionofdisease
- treatment
- tree nut allergy
- Tree-nut allergy
- Trichinella spiralis
- Tryptase
- TSLP: a key epithelial cytokine at the top of the asthma inflammatory cascade
- type 2 inflammation
- UCARE
- unmet needs
- Urban green spaces
- Urban particulate matter
- Urticaria
- urticaria in children
- urticarial vasculitis
- Vaccination
- vaccine
- Vaccines
- Vaping
- Venom and insect allergy
- venom immunotherapy
- Viral reactivation
- Virtual care
- Virus
- WAO
- wheal
- wheezing child
- white paper
- World Health Organization (WHO)
- WS 2023 Davos
- Xlinkedagammaglobulinemia
- yellow fever
- young adult
- young adults
- young children
Author
- Aberer, W.
- Achten, R.
- Adamiec, A.
- Adcock, I.
- Agache, I.
- Aggelides, X.
- Akdis, C.A.
- Akdis, M.
- Akin, C.
- Allegri, P.
- Altrichter, S.
- Alvarez-Cuesta, E.
- Alvarez-Perea, A.
- Alvaro-Lozano, M.
- Alviani, C.
- Ambrożej, D.
- Angier, E.
- Annesi-Maesano, I.
- Antolin-Amerigo, D.
- Antunes, C.
- Apoil, P.
- Arasi, S.
- Arcolaci, A.
- Ardern-Jones, M.R.
- Arkhipova, S.
- Arnold, A.
- Arrais, M.
- Asero, R.
- Atanaskovic-Markovic, M.
- Ayane, A.
- Aygören-Pürsün, E.
- Bacharier, L.
- Bachert, C.
- Baerenfaller, K.
- Bansal, P.
- Barbaud, A.
- Barber, D.
- Bartel, S.
- Bartra, J.
- Baumann, R.
- Bavbek, S.
- Bazan-Socha, S.
- Beausoleil, J.
- Beck, E.
- Beck, L.
- Bégin, P.
- Beken, B.
- Benito Villalvilla, C.
- Bergmann, C.
- Bernard, A.
- Bernstein, D.
- Bernstein, J.
- Besednjak-Kocijancic, L.
- Betschel, S.
- Beyer, K.
- Bianchini, R.
- Biedermann, T.
- Birrell, F.
- Bisyuk, Y.
- Blain, H.
- Blanca-Lopez, N.
- Blasi, F.
- Blümchen, K.
- Boccabella, C.
- Boguniewciz, M.
- Bohle, B.
- Böhm, I.
- Bonini, M.
- Borres, M.
- Bosco, A.
- Bosnic-Anticevich, S.
- Bossios, A.
- Bousquet, J.
- Boyce, J.
- Boyle, R.
- Bozek, A.
- Bozkurt, B.
- Braido, F.
- Branicka, O.
- Braun, A.
- Braunstahl, G.
- Bredenoord, A.
- Brignole-Baudouin, F.
- Brockow, K.
- Brough, H.A.
- Brucker, H.
- Brusselle, G.
- Burks, W.
- Busse, W.
- Caballero, M.
- Cabanillas, B.
- Cabrera, M.
- Calado, R.
- Calder, V.
- Calderon, M.
- Calvão, J.
- Camargo Lopes de Oliveira, L.
- Campbell, D.
- Canonica, G.W.
- Cardona, V.
- Carnés, J.
- Carter, M.
- Casale, T.
- Castells, M.
- Castillejo, G.
- Caubet, J.-C.
- Cavaleiro Rufo, J.
- Chaker, A.
- Chan, E.
- Chandra, A.
- Chawes, B.
- Chehade, M.
- Chivato, T.
- Cho, Y.
- Chung, K.
- Cianferoni, A.
- Cimbollek, S.
- Clark, A.
- Clark, E.
- Cogo, A.
- Cojanu, C.
- Comberiati, P.
- Constantinides, M.
- Corbett, M.
- Cornejo-Garcia, J.A.
- Corren, J.
- Corrigan, C.
- Coutinho, C.
- Couto, M.
- Craig, T.
- Cullinan, P.
- Cunha, I.
- Custovic, A.
- D'Amato, G.
- Davidescu, L.
- Dávila, I.
- de Blay, F.
- De Craemer, J.
- de Jong, N.
- de las Vecillas, L.
- de Silva, D.
- de Swart, R.
- de Waard-van der Spek, F.
- del Giacco, S.
- Delgado, L.
- Demoly, P.
- Descamps, V.
- Deschildre, A.
- Deshpande, D.
- di Bona, D.
- Diamant, Z.
- Diwakar, L.
- Doğru, M.
- Domínguez Andrés, J.
- Doña, I.
- Dörr, T.
- Dramburg, S.
- Drijver-Messelink, M.T.
- du Toit, G.
- Dunn Galvin, A.
- DunnGalvin, A.
- Durham, S.
- Eberlein, B.
- Ebisawa, M.
- Ebo, D.G.
- Eggel, A.
- Eguiluz-Gracia, I.
- Eguiluz, I.
- Eigenmann, P.
- Eiwegger, T.
- Elenius, V.
- Eljaszewicz, A.
- Emeryk, A.
- Emson, C.
- Eyerich, K.
- Fakhimahmadi, A.
- Farkas, H.
- Fauquert, J.
- Favaro, A.
- Feketea, G.
- Feleszko, W.
- Fernández Santamaría, R.
- Fernández-Rivas, M.
- Ferrando anaut, P.
- Fieten, K.B.
- Figueras Alsius, M.
- Fiocchi, A.
- Flokstra – de Blok, B.M.J.
- Florsheim, E.
- Fokkens, W.
- Fonseca, J.
- Forastiere, F.
- Freemantle, N.
- Fritzsching, B.
- Fu, W.
- Gainsborough, F.
- Galvan Blasco, P.
- Gamez, C.
- Gappa, M.
- Garvey, L.H.
- Gaudenzio, N.
- Gelincik, A.
- Geng, B.
- Gennery, A.
- Genuneit, J.
- Gern, J.
- Gerth van Wijk, R.
- Gervasoni, M.E.
- Gevaert, P.
- Gherasim, A.
- Giménez-Arnau, A.
- Giovannini, M.
- Gobert, D.
- Golding, M.
- Gomes, E.R.
- Gomes, J.
- Goncalo, M.
- Gonçalo, M.
- González Díaz, S.
- González germán, M.
- Goodman, R.
- Goossens, A.
- Gore, C.
- Grattan, C.
- Greenhawt, M.
- Grigg, J.
- Grimshaw, K.
- Gunawardana, N.
- Gupta, R.
- Gutermuth, J.
- Guttman-Yassky, E.
- Guttman, E.
- Hagemann, J.
- Halken, S.
- Hamilton, J.
- Hartmann, K.
- Heffler, E.
- Heine, R.
- Heldner, A.
- Hellings P.
- Hermuth-Kleinschmidt, K.
- Hilger, C.
- Hirahara, K.
- Hoffmann-Sommergruber, K.
- Holgate, S.
- Holmdahl, I.
- Holmes, S.
- Howarth, P.
- Huang, Y.
- Humbert, M.
- In't Veen, H.
- Izquierdo, E.
- Izuhara, K.
- Jackson, D.
- Jacobsen, L.
- Jakob, T.
- Janda, J.
- Jeebhay, M.
- Jeimy, S.
- Jensen-Jarolim, E.
- Jesenak, M.
- Jiménez-Saiz, R.
- Johnston, S.
- Jones, A.
- Juskiene, I.
- Jutel, M.
- K Chu, D.
- Kang, M.
- Kappen, J.
- Kase Tanno, L.
- Kelleher, M.
- Kessel, A.
- Khaitov, M.
- Khaleva, E.
- Kheradmand, F.
- Kiani-alikhan, S.
- Kılıç, A.
- Kleine-Tebbe, J.
- Kleuskens, M.
- Klimek, L.
- Knibb, R.
- Knol, E.
- Kocatürk, E.
- Köhler, V.
- Korath, A.D.J.
- Korn, S.
- Kortekaas Krohn, I.
- Kosowska, A.
- Kothalawala, D.
- Kozlik, P.
- Kucharczyk, A.
- Kuna, P.
- Kündig, T.
- Kupczyk, M.
- Kuziemski, K.
- Lack, G.
- Lang, D.
- Larché, M.
- Larenas-linnemann, D.
- Lau, S.
- Lauerma, A.
- Lee, Y.
- Leonardi, A.
- Levy, D.
- Liu, A.
- Lopata, A.
- Mack, D.
- Madrigal-Burgaleta, R.
- Magerl, M.
- Mahler, V.
- Mäkelä, M.
- Maleki, S.
- Malinovschi, A.
- Malmberg, P.L.
- Mantovani, A.
- Marcoux, D.
- Marrs, T.
- Marsella, R.
- Martins, C.
- Maspero, J.
- Mastalerz, L.
- Mathioudakis, A.
- Matricardi, P.
- Matucci, A.
- Maurer, M.
- Mayerhofer, H.
- Mayorga, C.
- McSorley, H.
- Melén, E.
- Menzies-Gow, A.
- Meyer, R.
- Michel, M.
- Mikkelsen, A.
- Mockenhaupt, M.
- Moloudizargari, M.
- Montimer, K.
- Mori, F.
- Mortz, C.G.
- Mösges, R.
- Moya, B.
- Mueller, R.S.
- Mukherjee, M.
- Mullol, J.
- Muraro, A.
- Myszkowska, D.
- Nadeau, K.C.
- Nasser, S.
- Novak, N.
- Nutten, S.
- Nwaru, B.
- O'B Hourihane, J.
- O’Mahony, L.
- Ogese, M.
- Ogg, G.
- Ogneva, D.
- Ollert, M.
- Ong, P.Y.
- Onorato, G.L.
- Pagani, M.
- Pali-Schöll, I.
- Paller, A.
- Palomares, O.
- Paoletti, G.
- Papadopoulos, N.
- Paplinska-Goryca, M.
- Park, H.
- Pascal, M.
- Pasmans, S.
- Pavlova, K.
- Pavord, I.
- Peden, D.
- Pérez de Llano, L.
- Perkin, M.
- Permaul, P.
- Peters, A.
- Pfaar, O.
- Pfaller, B.
- Pietikäinen, S.
- Pite, H.
- Pitsios, C.
- Poli, A.
- Popescu, F.
- Porsbjerg, C.
- Portelli, M.
- Price, O.J.
- Prunicki, M.
- Qazi, K.
- Quirce, S.
- Rabe, K.F.
- Radzikowska, U.
- Recke, A.
- Reese, I.
- Reginald, K.
- Renz, H.
- Reynolds, N.
- Ricci, C.
- Roberts, G.
- Roberts, G.
- Rodrigo-Muñoz, J.
- Rodrigues-Cernadas, J.
- Rodríguez Del Río, P.
- Rondon, C.
- Rossi, A.
- Rostaher, A.
- Roth-Walter, F.
- Rothenberg, M.
- Rouger, M.
- Rovati, G.E.
- Rubin, E.
- Rudenko, M.
- Rustemeyer, T.
- Ryan, D.
- Sabato, V.
- Sabouraud, D.
- Sadeghi, S.
- Sala Cunill, A.
- Salapatek, A.
- Sampson, H.
- Sandoval-Ruballos, M.
- Santos, A.
- Sastre, J.
- Satyaraj, E.
- Savic, S.
- Scadding, G.
- Scheib, N.
- Scherrer, K.
- Schmid, B.
- Schuijs, M.
- Schwarze, J.
- Sediva, A.
- Sekerel, B.
- Semernik, O.
- Serrano, C.
- Sevciovic Grumach, A.
- Shamji, M.H.
- Siebenhaar, F.
- Siegfried, E.
- Skypala, I.J.
- Smolinska, S.
- Sokolowska, M.
- Solinski, M.
- Song, K.
- Sorensen, K.
- Spanevello, A.
- Spergel, J.
- Spolak-Bobryk, N.
- Spriggs, K.
- Stevens, W.
- Stobiecki, M.
- Stratton. R.
- Straumann, A.
- Sturm, G.
- Sublett, J.
- Suojalehto, H.
- Suprun, M.
- Swanson, W.S.
- Szajewska, H.
- Szefler, S.
- Szymanski, L.
- Tan, B.
- Tanno, L.
- Tham, E.
- Thibaudon, M.
- Thien, F.
- Thirumala Krishna, M.
- Togias, A.
- Tomazic, P.
- Torrado español, I.
- Torres, M.J.
- Torun, E.
- Traidl-Hoffmann, C.
- Tramper-Stranders, G.
- Trautmann, A.
- Troy, N.
- Tsabouri, S.
- Tsilochristou, O.
- Ueki, S.
- Untersmayr, E.
- Vaia, E.
- Van Bilsen, J.
- Van Cuilenborg, V.
- van den Berge, M.
- Van Dijk, Y.
- van Neerven, R.
- van Ree, R.
- Van Schijndel, H.
- Van Weissenbruch, R.
- Vandenplas, Y.
- Vassilopoulou, E.
- Vazquez-Ortiz, M.
- Vega Castro, A.
- Venter, C.
- Verhasselt, V.
- Villaseñor solis, A.
- Vitte, J.
- Vlieg- Boerstra, B.
- Vogelberg, C.
- von Mutius, E.
- Vultaggio, A.
- Walsted, E.S.
- Walter, J.
- Wang, J.
- Wardzynska, A.
- Warner, A.
- Wechsler, M.
- Weidner, J.
- Weinberger, B.
- Werfel, T.
- Wiehn, E.
- Williams, S.
- Wong, C.
- Worm, M.
- Xepapadaki, V.
- Yepes-Nuñez, J.J.
- Yuste-Montalvo, A.
- Zednik, K.
- Zhang, L.
- Zieglmayer, P.
- Zissler, U.M.
- Zuberbier, T.

COVID-19 Resource 09/06/2022

Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy

Read about this COVID-19 Resource
COVID-19 Resource 09/06/2022

Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemic

Read about this COVID-19 Resource
COVID-19 Resource 09/06/2022

A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection

Read about this COVID-19 Resource
COVID-19 Resource 09/06/2022

Angiotensin‐converting enzyme II expression and its implication in the association between COVID‐19 and allergic rhinitis

Read about this COVID-19 Resource
COVID-19 Resource 09/06/2022

Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19

Read about this COVID-19 Resource
COVID-19 Resource 09/06/2022

The role of circulating eosinophils on COVID‐19 mortality varies by race/ethnicity

Read about this COVID-19 Resource
COVID-19 Resource 09/06/2022

Elastase and Exacerbation of Neutrophil Innate Immunity are Involved in Multi‐Visceral Manifestations of COVID‐19

Read about this COVID-19 Resource
COVID-19 Resource 02/04/2021

Skin tests in urticaria/angioedema and flushing to Pfizer‐BioNTech SARS‐CoV‐2 vaccine: limits of intradermal testing

Read about this COVID-19 Resource
COVID-19 Resource 02/04/2021

Vaccines and allergic reactions: the past, the current COVID‐19 pandemic, and future perspectives

Read about this COVID-19 Resource
COVID-19 Resource 27/03/2021

Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma Section

Read about this COVID-19 Resource
COVID-19 Resource 25/03/2021

Detection of SARS‐CoV‐2 Specific Memory B cells to Delineate Long‐Term COVID‐19 Immunity

Read about this COVID-19 Resource
COVID-19 Resource 18/03/2021

Pros and Cons for the role of air pollution on COVID-19 Development

Read about this COVID-19 Resource
COVID-19 Resource 17/03/2021

Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold – an ARIA- EAACI – GA2LEN consensus

Read about this COVID-19 Resource
COVID-19 Resource 03/03/2021

Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation

Read about this COVID-19 Resource
COVID-19 Resource 02/03/2021

COVID-19 Pandemic and allergen immunotherapy – an EAACI survey

Read about this COVID-19 Resource
COVID-19 Resource 01/03/2021

Impact of anxiety, stress and depression related to COVID-19 pandemic on the course of hereditary angioedema with C1 inhibitor deficiency

Read about this COVID-19 Resource
COVID-19 Resource 20/02/2021

Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort

Read about this COVID-19 Resource
COVID-19 Resource 11/02/2021

Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: data from the DA‐COVID‐19 registry

Read about this COVID-19 Resource
COVID-19 Resource 31/01/2021

Enzymatic activity of ACE2 regulates type 2 airway inflammation in mice

Read about this COVID-19 Resource
COVID-19 Resource 16/01/2021

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines

Read about this COVID-19 Resource
COVID-19 Resource 07/01/2021

Association of endopeptidases, involved in SARS‐CoV‐2 infection, with microbial aggravation in sputum of severe asthma

Read about this COVID-19 Resource
COVID-19 Resource 31/12/2020

Genetic Predisposition to allergic diseases is inversely associated to risk of COVID-19

Read about this COVID-19 Resource
COVID-19 Resource 30/12/2020

ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – an EAACI‐ARIA position paper

Read about this COVID-19 Resource
COVID-19 Resource 19/12/2020

SARS-COV-2 Candidate vaccines – composition, mechanisms of action and stages of clinical development

Read about this COVID-19 Resource
COVID-19 Resource 15/12/2020

Allergic reactions to the first COVID‐19 vaccine: a potential role of polyethylene glycol?

Read about this COVID-19 Resource
COVID-19 Resource 12/12/2020

Multidisciplinary consensus on sputum induction biosafety during the COVID-19 pandemic

Read about this COVID-19 Resource
COVID-19 Resource 07/12/2020

The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

Read about this COVID-19 Resource
COVID-19 Resource 28/11/2020

Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control & Prevention

Read about this COVID-19 Resource
COVID-19 Resource 19/11/2020

Distinct expression of SARS- CoV-2 receptor ACE2 correlates with endotypes of rhinosinusitis with nasal polyps

Read about this COVID-19 Resource
COVID-19 Resource 13/11/2020

Risk factors for severe and critically ill COVID-19 patients: A review

Read about this COVID-19 Resource
COVID-19 Resource 31/10/2020

Immunological imprint of COVID-19 on human peripheral blood leukocyte populations

Read about this COVID-19 Resource
COVID-19 Resource 28/10/2020

Is there a role for childhood vaccination against COVID-19?

Read about this COVID-19 Resource
COVID-19 Resource 19/10/2020

Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic – An EAACI Position Paper

Read about this COVID-19 Resource
COVID-19 Resource 10/10/2020

Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections

Read about this COVID-19 Resource
COVID-19 Resource 10/10/2020

Regional differences in ACE2 expression in the sinonasal mucosa of adult Chinese patients with chronic rhinosinusitis

Read about this COVID-19 Resource
COVID-19 Resource 04/10/2020

Characterization of asthma and risk factors for delayed SARS‐CoV‐2 clearance in adult COVID‐19 inpatients in Daegu

Read about this COVID-19 Resource
COVID-19 Resource 30/09/2020

Accuracy of serological testing for SARS‐CoV‐2 antibodies: first results of a large mixed‐method evaluation study

Read about this COVID-19 Resource
COVID-19 Resource 23/09/2020

Small droplet emission in exhaled breath during different breathing manoeuvres: Implications for clinical lung function testing during COVID‐19

Read about this COVID-19 Resource
COVID-19 Resource 18/09/2020

Asthma control, self‐management and healthcare access during the COVID‐19 epidemic in Beijing

Read about this COVID-19 Resource
COVID-19 Resource 15/09/2020

The younger the milder clinical course of COVID-19 – even in infants?

Read about this COVID-19 Resource
COVID-19 Resource 08/09/2020

The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic

Read about this COVID-19 Resource
COVID-19 Resource 07/09/2020

Thirty‐six COVID‐19 cases preventively vaccinated with mumps‐measles‐rubella vaccine: all mild course

Read about this COVID-19 Resource
COVID-19 Resource 16/08/2020

Atopic status protects from severe complications of COVID‐19

Read about this COVID-19 Resource
COVID-19 Resource 14/08/2020

Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma Registry

Read about this COVID-19 Resource
COVID-19 Resource 06/08/2020

Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19

Read about this COVID-19 Resource
COVID-19 Resource 05/08/2020

Shielding against SARS-CoV-2 infections is not justified in children with severe asthma

Read about this COVID-19 Resource
COVID-19 Resource 05/08/2020

Cross‐sectional pilot study exploring the feasibility of a rapid SARS‐CoV‐2 immunization test in health and nonhealthcare workers

Read about this COVID-19 Resource
COVID-19 Resource 05/08/2020

Delayed virus‐specific antibody responses associate with COVID‐19 mortality

Read about this COVID-19 Resource
COVID-19 Resource 02/08/2020

Blood myeloperoxidase‐DNA, a biomarker of early response to SARS‐CoV‐2 infection?

Read about this COVID-19 Resource
COVID-19 Resource 01/08/2020

COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

Read about this COVID-19 Resource
COVID-19 Resource 30/07/2020

Antibodies in serum of convalescent patients following mild COVID‐19 do not always prevent virus‐receptor binding

Read about this COVID-19 Resource
COVID-19 Resource 29/07/2020

Bacillus Calmette‐Guérin vaccination and socioeconomic variables vs COVID‐19 global features: Clearing up a controversial issue

Read about this COVID-19 Resource
COVID-19 Resource 29/07/2020

SARS‐CoV‐2 receptor ACE2 protein expression in serum is significantly associated with age

Read about this COVID-19 Resource
COVID-19 Resource 19/07/2020

A male infant with COVID-19 in the context of ARPC1B Deficiency

Read about this COVID-19 Resource
COVID-19 Resource 17/06/2020

Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection

Read about this COVID-19 Resource
COVID-19 Resource 09/06/2020

Postnatal SARS‐CoV‐2 Infection and Immunological Reaction: A Prospective Family Cohort Study

Read about this COVID-19 Resource
COVID-19 Resource 02/06/2020

First antibody trial launched in COVID-19 patients

Read about this COVID-19 Resource
COVID-19 Resource 29/05/2020

African American children are at higher risk for COVID‐19 infection

Read about this COVID-19 Resource
COVID-19 Resource 28/05/2020

SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues

Read about this COVID-19 Resource
COVID-19 Resource 26/05/2020

APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort

Read about this COVID-19 Resource
COVID-19 Resource 15/05/2020

Symptoms and immunoglobulin development in hospital staff exposed to a SARS‐CoV‐2 outbreak

Read about this COVID-19 Resource
COVID-19 Resource 02/05/2020

The first, holistic immunological model of COVID‐19: Implications for prevention, diagnosis, and public health measures

Read about this COVID-19 Resource
COVID-19 Resource 01/05/2020

Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during RED-ZONE declaration

Read about this COVID-19 Resource
COVID-19 Resource 24/04/2020

SARS‐CoV‐2 infection in children – Understanding the immune responses and controlling the pandemic

Read about this COVID-19 Resource
COVID-19 Resource 22/04/2020

Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2

Read about this COVID-19 Resource
COVID-19 Resource 22/04/2020

Successful containment of COVID‐19 outbreak in a large maternity and perinatal center while continuing clinical service

Read about this COVID-19 Resource
COVID-19 Resource 22/04/2020

Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover

Read about this COVID-19 Resource
COVID-19 Resource 22/04/2020

Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – the 2020 COVID‐19 pandemic – A statement from the EAACI-Section on Pediatrics

Read about this COVID-19 Resource
COVID-19 Resource 26/03/2020

COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic

Read about this COVID-19 Resource
COVID-19 Resource 24/03/2020

World Allergy Organization (WAO): Preparing your office for the COVID-19 Pandemic

Read about this COVID-19 Resource
COVID-19 Resource 16/03/2020

DGAKI statement on asthma and COVID-19

Read about this COVID-19 Resource

Show more COVID-19 Resources (59)

Covid-19 Resources

All Covid-19 Resources

What are you looking for?

Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy

Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemic

A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection

Angiotensin‐converting enzyme II expression and its implication in the association between COVID‐19 and allergic rhinitis

Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19

The role of circulating eosinophils on COVID‐19 mortality varies by race/ethnicity

Elastase and Exacerbation of Neutrophil Innate Immunity are Involved in Multi‐Visceral Manifestations of COVID‐19￼￼

Skin tests in urticaria/angioedema and flushing to Pfizer‐BioNTech SARS‐CoV‐2 vaccine: limits of intradermal testing

Vaccines and allergic reactions: the past, the current COVID‐19 pandemic, and future perspectives

Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma Section

Detection of SARS‐CoV‐2 Specific Memory B cells to Delineate Long‐Term COVID‐19 Immunity

Pros and Cons for the role of air pollution on COVID-19 Development

Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold – an ARIA- EAACI – GA2LEN consensus

Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation

COVID-19 Pandemic and allergen immunotherapy – an EAACI survey

Impact of anxiety, stress and depression related to COVID-19 pandemic on the course of hereditary angioedema with C1 inhibitor deficiency

Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort￼

Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: data from the DA‐COVID‐19 registry

Enzymatic activity of ACE2 regulates type 2 airway inflammation in mice

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines

Association of endopeptidases, involved in SARS‐CoV‐2 infection, with microbial aggravation in sputum of severe asthma

Genetic Predisposition to allergic diseases is inversely associated to risk of COVID-19

ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – an EAACI‐ARIA position paper

SARS-COV-2 Candidate vaccines – composition, mechanisms of action and stages of clinical development ￼

Allergic reactions to the first COVID‐19 vaccine: a potential role of polyethylene glycol?￼

Multidisciplinary consensus on sputum induction biosafety during the COVID-19 pandemic

The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control & Prevention

Distinct expression of SARS- CoV-2 receptor ACE2 correlates with endotypes of rhinosinusitis with nasal polyps

Risk factors for severe and critically ill COVID-19 patients: A review

Immunological imprint of COVID-19 on human peripheral blood leukocyte populations

Is there a role for childhood vaccination against COVID-19?￼

Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic – An EAACI Position Paper

Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections

Regional differences in ACE2 expression in the sinonasal mucosa of adult Chinese patients with chronic rhinosinusitis

Characterization of asthma and risk factors for delayed SARS‐CoV‐2 clearance in adult COVID‐19 inpatients in Daegu

Accuracy of serological testing for SARS‐CoV‐2 antibodies: first results of a large mixed‐method evaluation study

Small droplet emission in exhaled breath during different breathing manoeuvres: Implications for clinical lung function testing during COVID‐19

Asthma control, self‐management and healthcare access during the COVID‐19 epidemic in Beijing

The younger the milder clinical course of COVID-19 – even in infants? ￼

The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic

Thirty‐six COVID‐19 cases preventively vaccinated with mumps‐measles‐rubella vaccine: all mild course

Atopic status protects from severe complications of COVID‐19

Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma Registry

Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19

Shielding against SARS-CoV-2 infections is not justified in children with severe asthma ￼

Cross‐sectional pilot study exploring the feasibility of a rapid SARS‐CoV‐2 immunization test in health and nonhealthcare workers

Delayed virus‐specific antibody responses associate with COVID‐19 mortality

Blood myeloperoxidase‐DNA, a biomarker of early response to SARS‐CoV‐2 infection?

COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

Antibodies in serum of convalescent patients following mild COVID‐19 do not always prevent virus‐receptor binding

Bacillus Calmette‐Guérin vaccination and socioeconomic variables vs COVID‐19 global features: Clearing up a controversial issue

SARS‐CoV‐2 receptor ACE2 protein expression in serum is significantly associated with age

A male infant with COVID-19 in the context of ARPC1B Deficiency

Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection

Postnatal SARS‐CoV‐2 Infection and Immunological Reaction: A Prospective Family Cohort Study

First antibody trial launched in COVID-19 patients

African American children are at higher risk for COVID‐19 infection

SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues

APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort

Symptoms and immunoglobulin development in hospital staff exposed to a SARS‐CoV‐2 outbreak

The first, holistic immunological model of COVID‐19: Implications for prevention, diagnosis, and public health measures

Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during RED-ZONE declaration

SARS‐CoV‐2 infection in children – Understanding the immune responses and controlling the pandemic

Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2

Successful containment of COVID‐19 outbreak in a large maternity and perinatal center while continuing clinical service

Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover

Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – the 2020 COVID‐19 pandemic – A statement from the EAACI-Section on Pediatrics

COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic

World Allergy Organization (WAO): Preparing your office for the COVID-19 Pandemic

DGAKI statement on asthma and COVID-19

Elastase and Exacerbation of Neutrophil Innate Immunity are Involved in Multi‐Visceral Manifestations of COVID‐19

Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort

SARS-COV-2 Candidate vaccines – composition, mechanisms of action and stages of clinical development

Allergic reactions to the first COVID‐19 vaccine: a potential role of polyethylene glycol?

Is there a role for childhood vaccination against COVID-19?

The younger the milder clinical course of COVID-19 – even in infants?

Shielding against SARS-CoV-2 infections is not justified in children with severe asthma